THE DEAL, AT A GLANCE
From the announcementTerray Therapeutics
01Who is involvedBacked by VariousFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02What happenedTerray Therapeutics raised $120M Series AFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03Why it mattersTerray Therapeutics is using Series A capital to convert AI-miniaturized chemistry screening capacity into oncology clinical candidates.From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Terray Therapeutics · Financing Record
Explore source-linked visual explanations for Terray Therapeutics. Unsupported claims are withheld while source review continues.
Record 865 · Recorded date: Needs review
What it does
Unsupported business claims are withheld pending source review. Explore the linked records for available evidence.
Explore company records →